荆瑞娟

[摘要] 目的 研究依达拉奉治疗糖尿病并发脑梗死疗效。方法 选取该院在2014年3月—2017年3月期间收治的50例糖尿病并发脑梗死患者，对其进行研究。按照随机数字表法，将其分为实验组和参照组，各25例。将采取常规药物治疗的患者作为参照组，将在参照组的基础上加以依达拉奉药物治疗的患者作为实验组。对比两组患者的治疗效果。结果 对比两组患者治疗前后的ADL评分，治疗前组间差异无统计学意义（P>0.05）；治疗后组间差异有统计学意义（P<0.05）。对两组患者的治疗总有效率进行比较，实验组患者明显优于参照组，组间差异有统计学意义（P<0.05）。结论 对糖尿病并发症患者采取依达拉奉药物治疗，提高了治疗总有效率，值得临床上借鉴以及进一步普及。

[关键词] 依达拉奉；糖尿病；脑梗塞；治疗效果

[中图分类号] R743 [文献标识码] A [文章编号] 1672-4062（2017）05（b）-0085-02

[Abstracts] Objective This paper tries to study the curative effect of edaravone on diabetic patients with cerebral infarction. Methods 50 cases of diabetic patients with cerebral infarction from March 2014 to March 2017 were selected and studied and divided into two groups according to the random number table method， with 25 cases in each group. The patients with routine medicine treatment were regarded as the control group， and the patients added edaravone for treatment were regarded as the experimental group. The treatment effects of the two groups were compared. Results The ADL scores before and after treatment of the two groups were compared， and there was no significant difference between the two groups before the treatment and the difference was not obvious（P>0.05）， while that difference was significant of the two groups after treatment， and that of the experimental group was better than the control group（P<0.05）. The total effectiveness of the two groups of patients was compared， and that of the experimental group was significantly better than the control group， and the difference between the groups was statistically significant（P<0.05）. Conclusion The application of edaravone for the treatment of diabetic patients with cerebral infarction is effective and it is worth the clinical reference and further popularization.

[Key words] Edaravone； Diabetes mellitus； Cerebral infarction； Treatment effect

在臨床上，糖尿病是一种最为常见的疾病，糖尿病并发脑梗死具有较高的发病率、致死率和致残率，对人类的生命健康具有严重的威胁[1]。该对该院于2014年3月—2017年3月收治的50例糖尿病并发脑梗死患者进行研究，现报道如下。

1 资料与方法

1.1 一般资料

选取该院在收治的50例糖尿病并发脑梗死患者作为研究对象，进行研究。所有患者经常规检验，均确诊为糖尿病并发脑梗死疾病。将其按照随机数字表法分为两组，实验组（n=25）和参照组（n=25）。实验组患者中，女性患者12例，男性患者13例，最小年龄为40岁，最大年龄为63岁，平均年龄为（53.35±1.68）岁；参照组患者中，女性患者10例，男性患者15例，最小年龄为40岁，最大年龄为65岁，平均年龄为（53.18±1.73）岁。对比两组患者的临床数据如性别、年龄等指标，差异无统计学意义（P>0.05）。

1.2 方法

在入院当天，对所有患者进行血糖检测，主要有餐前血糖、餐后2 h血糖、空腹血糖（FPG）、糖化血红蛋白（HbA1c）。参……